The influence of autologous lymphokine-activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin-2.

Albertini MR, Sosman JA, Hank JA, Moore KH, Borchert A, Schell K, Kohler PC, Bechhofer R, Storer B, Sondel PM
Cancer. 1990 66 (12): 2457-64

PMID: 2249185 · DOI:10.1002/1097-0142(19901215)66:12<2457::aid-cncr2820661203>;2-l

MeSH Terms (18)

Adult Aged Blood Transfusion, Autologous Carcinoma, Renal Cell Combined Modality Therapy Female Hodgkin Disease Humans Immunotherapy, Adoptive Infusions, Parenteral Interleukin-2 Kidney Neoplasms Killer Cells, Lymphokine-Activated Male Melanoma Middle Aged Neoplasms Recombinant Proteins

Connections (1)

This publication is referenced by other Labnodes entities: